Literature DB >> 19663386

2-Arylamino-4-amino-5-aroylthiazoles. "One-pot" synthesis and biological evaluation of a new class of inhibitors of tubulin polymerization.

Romeo Romagnoli1, Pier Giovanni Baraldi, Maria Dora Carrion, Olga Cruz-Lopez, Carlota Lopez Cara, Giuseppe Basso, Giampietro Viola, Mohammed Khedr, Jan Balzarini, Siavosh Mahboobi, Andreas Sellmer, Andrea Brancale, Ernest Hamel.   

Abstract

The essential role of microtubules in mitosis makes them a major target of compounds useful for cancer therapy. In our search for potent antitumor agents, a novel series of 2-anilino-4-amino-5-aroylthiazoles was synthesized and evaluated for antiproliferative activity, inhibition of tubulin polymerization, and cell cycle effects. SAR was elucidated with various substitutions on the phenylamino and aroyl moiety at the 2- and 5-positions, respectively, of the 4-aminothiazole skeleton. Tumor cell exposure to several of these compounds led to the arrest of HeLa cells in the G2/M phase of the cell cycle and induction of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19663386      PMCID: PMC2762271          DOI: 10.1021/jm9001692

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Synthesis and structure-activity relationship of 2-aminobenzophenone derivatives as antimitotic agents.

Authors:  Jing-Ping Liou; Chun-Wei Chang; Jeng-Shin Song; Yung-Ning Yang; Ching-Fang Yeh; Huan-Yi Tseng; Yu-Kang Lo; Yi-Ling Chang; Chung-Ming Chang; Hsing-Pang Hsieh
Journal:  J Med Chem       Date:  2002-06-06       Impact factor: 7.446

2.  Microtubule structure and its stabilisation.

Authors:  Linda A Amos
Journal:  Org Biomol Chem       Date:  2004-07-14       Impact factor: 3.876

3.  Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain.

Authors:  Raimond B G Ravelli; Benoît Gigant; Patrick A Curmi; Isabelle Jourdain; Sylvie Lachkar; André Sobel; Marcel Knossow
Journal:  Nature       Date:  2004-03-11       Impact factor: 49.962

4.  [4-(imidazol-1-yl)thiazol-2-yl]phenylamines. A novel class of highly potent colchicine site binding tubulin inhibitors: synthesis and cytotoxic activity on selected human cancer cell lines.

Authors:  Siavosh Mahboobi; Andreas Sellmer; Heymo Höcher; Emerich Eichhorn; Thomas Bär; Mathias Schmidt; Thomas Maier; Josef F Stadlwieser; Thomas L Beckers
Journal:  J Med Chem       Date:  2006-09-21       Impact factor: 7.446

5.  Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin.

Authors:  C M Lin; H H Ho; G R Pettit; E Hamel
Journal:  Biochemistry       Date:  1989-08-22       Impact factor: 3.162

6.  4-Amino-5-benzoyl-2-(4-methoxyphenylamino)thiazole (DAT1): a cytotoxic agent towards cancer cells and a probe for tubulin-microtubule system.

Authors:  Suparna Sengupta; Sasidharan L Smitha; Nisha E Thomas; Thankaiyyan R Santhoshkumar; Satyabhama K C Devi; Kumaran G Sreejalekshmi; Kallikat N Rajasekharan
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

7.  Antineoplastic agents. 379. Synthesis of phenstatin phosphate.

Authors:  G R Pettit; B Toki; D L Herald; P Verdier-Pinard; M R Boyd; E Hamel; R K Pettit
Journal:  J Med Chem       Date:  1998-05-07       Impact factor: 7.446

8.  Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.

Authors:  G R Pettit; S B Singh; E Hamel; C M Lin; D S Alberts; D Garcia-Kendall
Journal:  Experientia       Date:  1989-02-15

9.  Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Vincent Remusat; Maria Dora Carrion; Carlota Lopez Cara; Delia Preti; Francesca Fruttarolo; Maria Giovanna Pavani; Mojgan Aghazadeh Tabrizi; Manlio Tolomeo; Stefania Grimaudo; Jan Balzarini; Mary Ann Jordan; Ernest Hamel
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

10.  New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies.

Authors:  Gabriella De Martino; Michael C Edler; Giuseppe La Regina; Antonio Coluccia; Maria Chiara Barbera; Denise Barrow; Robert I Nicholson; Gabriela Chiosis; Andrea Brancale; Ernest Hamel; Marino Artico; Romano Silvestri
Journal:  J Med Chem       Date:  2006-02-09       Impact factor: 7.446

  10 in total
  9 in total

Review 1.  Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2009.

Authors:  Roland E Dolle; Bertrand Le Bourdonnec; Karin Worm; Guillermo A Morales; Craig J Thomas; Wei Zhang
Journal:  J Comb Chem       Date:  2010-10-05

2.  Synthesis, antimitotic and antivascular activity of 1-(3',4',5'-trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazoles.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Maria Kimatrai Salvador; Filippo Prencipe; Valerio Bertolasi; Michela Cancellieri; Andrea Brancale; Ernest Hamel; Ignazio Castagliuolo; Francesca Consolaro; Elena Porcù; Giuseppe Basso; Giampietro Viola
Journal:  J Med Chem       Date:  2014-07-28       Impact factor: 7.446

3.  One-pot synthesis and biological evaluation of 2-pyrrolidinyl-4-amino-5-(3',4',5'-trimethoxybenzoyl)thiazole: a unique, highly active antimicrotubule agent.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Carlota Lopez Cara; Maria Kimatrai Salvador; Roberta Bortolozzi; Giuseppe Basso; Giampietro Viola; Jan Balzarini; Andrea Brancale; Xian-Hua Fu; Jun Li; Su-Zhan Zhang; Ernest Hamel
Journal:  Eur J Med Chem       Date:  2011-10-15       Impact factor: 6.514

4.  Development of SKI-349, a dual-targeted inhibitor of sphingosine kinase and microtubule polymerization.

Authors:  Jeremy A Hengst; Shailaja Hegde; Robert F Paulson; Jong K Yun
Journal:  Bioorg Med Chem Lett       Date:  2020-07-28       Impact factor: 2.823

5.  In-silico Investigation of Tubulin Binding Modes of a Series of Novel Antiproliferative Spiroisoxazoline Compounds Using Docking Studies.

Authors:  Hoda Abolhasani; Afshin Zarghi; Maryam Hamzeh-Mivehroud; Ali Akbar Alizadeh; Javid Shahbazi Mojarrad; Siavoush Dastmalchi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

6.  2-anilino-4-amino-5-aroylthiazole-type compound AS7128 inhibits lung cancer growth through decreased iASPP and p53 interaction.

Authors:  Hao-Wei Cheng; Rong-Jie Chein; Ting-Jen Cheng; Pei-Shan Wu; Hsin-Yi Wu; Pei-Fang Hung; Chia-Jen Wang; Yuan-Ling Hsu; Jau-Min Wong; Ang Yuan; Chi-Huey Wong; Pan-Chyr Yang; Szu-Hua Pan
Journal:  Cancer Sci       Date:  2018-02-06       Impact factor: 6.716

7.  Synthesis and Biological Evaluation of 2-Substituted Benzyl-/Phenylethylamino-4-amino-5-aroylthiazoles as Apoptosis-Inducing Anticancer Agents.

Authors:  Paola Oliva; Valentina Onnis; Elisa Balboni; Ernest Hamel; Francisco Estévez-Sarmiento; José Quintana; Francisco Estévez; Andrea Brancale; Salvatore Ferla; Stefano Manfredini; Romeo Romagnoli
Journal:  Molecules       Date:  2020-05-06       Impact factor: 4.411

8.  Synthesis and biological evaluation of oxazinonaphthalene-3-one derivatives as potential anticancer agents and tubulin inhibitors.

Authors:  Salimeh Mirzaei; Maqsudjon Qayumov; Fahimeh Gangi; Javad Behravan; Razieh Ghodsi
Journal:  Iran J Basic Med Sci       Date:  2020-11       Impact factor: 2.699

9.  ERK mediated upregulation of death receptor 5 overcomes the lack of p53 functionality in the diaminothiazole DAT1 induced apoptosis in colon cancer models: efficiency of DAT1 in Ras-Raf mutated cells.

Authors:  Reshma Thamkachy; Rohith Kumar; K N Rajasekharan; Suparna Sengupta
Journal:  Mol Cancer       Date:  2016-03-08       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.